Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you take fexofenadine for hay fever or chronic urticaria and you're starting Mounjaro (tirzepatide) for weight management, the key question is whether the two interact in a clinically meaningful way. The short answer is reassuring: no pharmacokinetic interaction between fexofenadine and tirzepatide has been identified in the prescribing literature, and fexofenadine does not appear on tirzepatide's list of medicines requiring special monitoring. That said, Mounjaro slows gastric emptying, which can influence how quickly any orally taken medicine is absorbed — and that's worth understanding before you start. As a prescription-only medicine, Mounjaro requires a clinical assessment; a prescriber reviews your full medication list, including antihistamines, as part of that process.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Mounjaro works partly by slowing the rate at which the stomach empties its contents into the small intestine. For most people, this is what produces a prolonged feeling of fullness after meals, a core part of how the treatment supports weight loss. The same mechanism, though, means that oral medicines taken at a similar time may reach the small intestine more slowly than they otherwise would.
Fexofenadine is absorbed in the small intestine, so in theory a delayed gastric-emptying effect could push back the time at which plasma concentrations peak. In practice, the clinical significance of this appears to be small for fexofenadine specifically. Unlike some other antihistamines, fexofenadine is not a CYP enzyme substrate in the usual sense, and tirzepatide's interaction data (reviewed in the Mounjaro Summary of Product Characteristics on the eMC) does not flag fexofenadine as a concern. The SmPC does note that the effect on oral contraceptives and other time-sensitive medicines is a consideration, which is why the oral contraceptive guidance specifically recommends adding a barrier method for the first four weeks of each dose step.
For a once-daily antihistamine taken primarily for symptom relief rather than at a precise therapeutic window, a modest shift in absorption timing is unlikely to affect how well it works day to day. That said, your own experience matters: if you notice your allergy symptoms feel less controlled after starting Mounjaro, it's a straightforward conversation to have with your prescriber.
Most people taking fexofenadine alongside Mounjaro do not need to change anything. Fexofenadine is typically taken once a day, and unlike some medicines with narrow therapeutic windows, it builds a relatively forgiving plasma profile. There's no established clinical recommendation to separate the timing of fexofenadine and your Mounjaro injection, the weekly injection format means absorption timing of the two medicines doesn't overlap in the same way it might with a daily injection or oral GLP-1.
Where timing does become relevant is with food and drink. Fexofenadine absorption is noted on the NHS medicines pages to be reduced by fruit juice, grapefruit, orange and apple juice in particular can lower plasma levels significantly. That interaction is between fexofenadine and juice, not between fexofenadine and tirzepatide, but it's worth being aware of because patients starting Mounjaro sometimes change their diet and drink more fruit juice as an alternative to sugary drinks.
The practical upshot: continue taking fexofenadine as you normally would. Keep your prescriber and GP informed that you take it, since that's standard good practice when starting any new medicine. You can read more about how Mounjaro fits into a broader weight-management plan on the Mounjaro overview page.
There are a few situations where the fexofenadine-plus-Mounjaro picture deserves more attention than the standard reassurance.
First, if your allergy is severe enough that you're taking fexofenadine at the upper end of the dosing range, or combining it with other antihistamines or decongestants, it's worth listing everything clearly on your consultation form. A prescriber reviewing a long medication list approaches it differently from reviewing a single antihistamine entry, and completeness on your end makes their job easier.
Second, if you're starting Mounjaro and you experience significant nausea or vomiting in the early weeks (a common GI side effect that often settles within the first couple of weeks) any oral medicine you take during that period may not be absorbed normally. That applies broadly, not just to fexofenadine. The MHRA's Drug Safety Update guidance on GLP-1 medicines covers GI side effects and when they warrant medical review. Persistent vomiting is a reason to contact your prescriber rather than push through.
Third, some people taking fexofenadine are doing so for a chronic urticaria that has an autoimmune component. Weight loss itself (whether from Mounjaro or any other cause) can affect inflammatory conditions in complex ways. That's a conversation for your GP or specialist, not something to navigate by adjusting your antihistamine independently. If you're curious about how the commercial name for tirzepatide relates to the broader pharmacology, that page covers it in plain language. For questions about cost or what treatment includes, the Mounjaro cost page sets out what's included in a private prescription.
It's understandable to wonder whether a routine antihistamine is even worth mentioning on a weight-loss consultation form. People worry about being turned down over something minor, or they forget to list medicines they've taken for years without thinking twice. Our prescribers genuinely want the full picture, not to find reasons to say no, but because it's how they give you advice that's actually tailored to you rather than a generic template.
Fexofenadine is unlikely to affect whether you're clinically suitable for Mounjaro. What matters is that your prescriber knows about it, notes it, and can factor it in if anything unexpected comes up during treatment. That's the same principle that applies to vitamins, supplements, contraceptives, and the occasional painkiller. Completeness on the intake form is the simplest safety step you can take.
If you take other medicines alongside fexofenadine, it may be worth reading about alcohol and Mounjaro or some of the other combination queries our prescribers see regularly, since the same principle of full disclosure applies across the board. You might also find it interesting to read about Nadine Dorries and her experience with Mounjaro, which touches on how the treatment has entered broader public discussion. Some patients also have questions about how Mounjaro can affect urine, which is another area worth understanding as you settle into treatment. When you're ready to explore whether Mounjaro is right for your situation, check your eligibility with a free consultation and a GPhC-registered prescriber will review your medication list the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.